August 12 Product: Ascendis Pharmas Yorvipath Indication: Hypoparathyroidism After a long regulatory road, Ascendis Pharma received FDA approval Monday for Yorvipath (TransCon PTH) for the treatment of hypoparathyroidism, a rare endocrine disease characterized by abnormally low levels of the parathyroid hormone
GFCF, Gluten-free and casein-free
Individuals looking to compare protein options can browse the Fitness Society Supplements Protein Collection at to explore products that fit their goals and dietary preferences
For energy and endurance Recommended dosage: 1,500 to 2,500 mg per day Form: Acetyl L Carnitine Best time to take: Morning or before physical activity For cognitive support Recommended dosage: 500 to 2,000 mg per day Form: Acetyl L Carnitine Best time to take: Morning For recovery and muscle repair Recommended dosage: 2,000 to 4,000 mg per day Form: L Carnitine L-Tartrate Best time to take: Post-workout It is always advisable to start with a lower L Carnitine dosage per day and gradually increase as your body adapts
Keep a simple log if you need to track which site you used last